文献速递针灸推拿中医内科

电针联合艾灸治疗重性抑郁障碍的随机假针对照预试验

Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.
PubMed 文献 · Integr Med Res · 2021-11-03

主要结局即汉密尔顿抑郁量表总分从基线至第9周平均变化组间差异无统计学意义(p=0.2641),两组量表分均显著改善;不良事件发生率组间无显著差异(p=0.1067)。结论认为该疗法用于重性抑郁障碍的临床试验可行,但需更大样本和理想对照进一步验证疗效与安全性。

要点

  • 电针联合艾灸治疗重性抑郁障碍的临床试验操作可行。
  • 主要结局HRSD总分变化组间差异无统计学意义(p=0.2641)。
  • 不良事件发生率组间无显著差异(p=0.1067),安全性待验证。

核心结论

  • 电针联合艾灸治疗重性抑郁障碍的临床试验看来可行,但疗效与安全性尚需更大样本、理想对照的研究确认。

研究设计与样本

  • 治疗组接受电针联合艾灸,对照组在非穴位接受假干预,疗程8周。

主要发现

  • 主要结局汉密尔顿抑郁量表总分从基线至第9周平均变化组间差异无统计学意义(p=0.2641)。
  • 两组汉密尔顿抑郁量表评分治疗后均显著改善。
  • 次要结局指标组间均无显著差异。
  • 不良事件发生率组间无显著差异(p=0.1067)。

临床怎么用

  • 该预试验结果尚不能支持电针联合艾灸作为重性抑郁障碍的确定有效疗法,临床决策需结合更大样本证据。

局限性

  • 对照组采用非穴位假干预,非理想对照。
  • 需更大样本和理想对照研究确认疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The first treatment option for major depressive disorder (MDD) is antidepressants, however, there is substantial demand for alternative therapies due to its low compliance and remission rates. This study was aimed to explore the effectiveness, safety, and feasibility of electroacupuncture plus moxibustion therapy for MDD. METHODS: Thirty adults with MDD were randomly assigned to the treatment group (TG) or control group (CG). The TG was treated with electroacupuncture plus moxibustion, and the CG received sham interventions at non-acupoints for 8 weeks. The primary outcome measure was the intergroup difference of the mean change of total score of the Hamilton rating scale for depression (HRSD) between baseline and week 9. Secondary outcome measures were Beck's depression inventory, insomnia severity index, the state-trait anxiety inventory, the EuroQol-5 dimension index, the measure yourself medical outcome profile version 2, and frontal alpha asymmetry measured by electroencephalography. Adverse events (AEs) were monitored for safety assessment. RESULTS: The primary outcome measure was not significantly different between the two groups (p=0.2641), although the scores of HRSD in both groups improved significantly after treatment. No significant difference was identified between groups in secondary outcome measures. The incidence of AE was not significantly different between the two groups (p=0.1067). CONCLUSION: A clinical trial using electroacupuncture plus moxibustion for MDD seems feasible. However, further studies with the larger size, adopting ideal controls are warranted to provide a confirmative conclusion to the efficacy and safety of electroacupuncture plus moxibustion for MDD. TRIAL REGISTRATION: The protocol was registered at Korean Clinical Trial Registry (CRIS-KCT0001810).

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Kim M, Choi EJ, Kwon OJ, et al. Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial. Integr Med Res. 2021. PMID: 34840949. doi:10.1016/j.imr.2021.100802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。